Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia

Translocation t(12;21), resulting in the ETV6-RUNX1 (or TEL-AML1) fusion protein, is present in 25% of pediatric patients with B-cell precursor acute lymphoblastic leukemia and is considered a first hit in leukemogenesis. A targeted therapy approach is not available for children with this subtype of...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Roel Polak, Marc B. Bierings, Cindy S. van der Leije, Mathijs A. Sanders, Onno Roovers, João R. M. Marchante, Judith M. Boer, Jan J. Cornelissen, Rob Pieters, Monique L. den Boer, Miranda Buitenhuis
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Ferrata Storti Foundation 2019-04-01
Saila:	Haematologica
Sarrera elektronikoa:	https://haematologica.org/article/view/8848
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!